Phase 3 Breast Cancer Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People aged 18 to 85 years old
• People who have had a full surgical removal of the breast (radical mastectomy) and now need follow-up chemotherapy using a treatment combination of docetaxel and cyclophosphamide
• People with a general health and activity level rated as reasonably functional (scored 0–2 on a standard medical scale)
• People whose blood counts fall within acceptable ranges — specifically, platelets, white blood cells, and infection-fighting cells (neutrophils) all above set minimum levels
• People whose liver function tests show bilirubin and liver enzymes within acceptable limits
• People with no fluid build-up in the abdomen, no bowel blockage, normal blood clotting, and a blood protein (albumin) level of at least 30g/L
• People whose liver function is rated as "Grade A" on a standard medical scoring system
• People whose kidney function is within a normal range, either by blood test or by a calculated measure of how well the kidneys filter waste

Who may not be able to join:

• People with a local skin infection or inflammation around the ear
• People with a tendency to bleed easily or a disorder affecting blood clotting
• People with significant fluid build-up in the abdomen (severe ascites)
• People with a blockage in the bowel or digestive tract
• People experiencing a severe sudden spike in blood pressure (hypertensive crisis) or blood pressure affecting the brain
• People with serious uncontrolled conditions such as active infection or poorly controlled diabetes
• People with significant heart or blood vessel problems, including a stroke or heart attack in the past 6 months, poorly controlled high blood pressure, unstable chest pain, heart failure, or a heart rhythm problem requiring medication
• People with a history of, or signs of, central nervous system conditions such as a primary brain tumour, uncontrolled epilepsy, any past brain metastases, or stroke
• People with a known allergy or sensitivity to any of the medications used in the trial
• People who are pregnant or currently breastfeeding
• People who have other illnesses, physical impairments, or findings on examination that suggest the study treatments could be unsafe or cause serious complications
• People who are unwilling or unable to follow the requirements of the study plan

Important: Always verify eligibility with the trial site directly before applying.